Controlled-Release Methylphenidate Improves Attention During On-Road Driving by Adolescents with Attention-Deficit/Hyperactivity Disorder

References

1. ↵
   American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
2. ↵
   Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990; 29: 546–57.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry 1985; 42: 937–47.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Liebson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001; 286: 60–6.

   OpenUrl
5. Jensen PS, Shervette RE, Xenakis SN, Bain MW. Psychosocial and medical histories of stimulant-treated children. J Am Acad Child Adolesc Psychiatry 1988; 27: 798–801.

   OpenUrlPubMedWeb of Science
6. DiScala C, Lescohier I, Barthel M, Li G. Injuries to children with attention deficit/hyperactivity disorder. Pediatrics 1998; 102: 1415–21.

   OpenUrlAbstract/FREE Full Text
7. ↵
   Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 1993; 92: 212–8.

   OpenUrlAbstract/FREE Full Text
8. ↵
   Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996; 98: 1089–95.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000; 188: 230–4.

   OpenUrlCrossRefPubMedWeb of Science
10. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Comp Psychiatry 1996; 37: 393–401.

    OpenUrl
11. ↵
    Shader RI, Harmatz JS, Oesterheld JR, Parmelee DX, Sallee FR, Greenblatt DJ. Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder. J Clin Pharmacol 1999; 39: 775–85.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56: 1073–86.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Swanson J, Gupta S, Guinta D, et al. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 1999; 66: 295–305.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2004; 43: 269–75.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Swanson J, Gupta S, Lam A, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of ADHD: proof of concept and proof of product studies. Arch Gen Psychiatry 2003; 60: 204–11.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    DuPaul G, Power T, Anastopoulos A, Reid R. ADHD rating scale-IV. New York: Guilford Press; 1998.
17. ↵
    Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000; 39: 28–38.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed. New York: Guilford Press; 1998.
19. ↵
    Biederman J. Practical considerations in stimulant drug selection for the attention-deficit/hyperactivity patient—efficacy, potency and titration. Today’s Therapeutic Trends 2002; 20: 311–28.

    OpenUrl
20. ↵
    Hunt DK, Lowenstein SR, Badgett RG, Steiner JE. Safety belt nonuse by internal medicine patients: a missed opportunity in clinical preventive medicine. Am J Med 1995; 98: 343–8.

    OpenUrlCrossRefPubMedWeb of Science